Azacitidine Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Azacitidine Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Dec 22, 2020. Reported reason: Other

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
68001-313-56
Dosage Form
Injection
Presentation
Azacitidine, Injection, 100 mg (NDC 68001-313-56)
Initial Posting
Dec 22, 2020

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.